top of page
RUA small logo-blue_edited.png
  • White Facebook Icon
  • White Instagram Icon
  • X
  • LinkedIn
  • TikTok
Abstract Waves

The Potential of Breath Analysis

Reimagine POC Diagnostics.

Volatile Organic Compounds in the Breath
Many disease states cause detectable changes in Volatile Organic Compounds (VOCs) which present in the lungs, as a result of disease-driven alterations in metabolic processes.
Tracked with Gas Chromatography (GC)
With one easily obtained, non-invasive breath sample, gas
chromatography separates and detects these compounds to
create a map of an individual’s VOCs.
Used to Identify, Diagnose & Monitor Disease
Machine learning models can then be trained to analyze combinations
of VOCs to identify the presence of specific diseases, track their
progression and predict the outcome of potential interventions.
ABOUT

A Micro GC Device with 
Benchtop Performance

Rua is revolutionizing healthcare with the first portable micro-GC (µGC) device, offering parts-per-trillion sensitivity previously only available in large laboratory systems. Powered by advanced photo-ionization and microfluidic technology, this fully automated device delivers fast, precise diagnostic results in just 30 minutes, regardless of the care setting. Rua’s µGC captures critical volatile organic compounds (VOCs) in exhaled breath, providing high-quality data that powers trained AI and machine learning algorithms to identify and monitor many diseases with a single breath sample. This breakthrough enables early disease detection, dynamic health tracking, and sets a new standard for personalized diagnostics & care across a range of conditions.

Untitled design (39).png

WORLDWIDE

Image for showcase only*

Discovering the power of RUA

Tracked with Gas
Chromatography (GC)

Novel photo-ionization technology utilizing microfluidics is able to accurately detect VOCs with parts per trillion sensitivity.

Fully Automated Software Analysis in 30 minutes or less

Trained proprietary algorithms will analyze device data to diagnose & assess diseases and predict patient outcomes.

Platform Screens for Multiple Diseases with Only One Breath Sample

Easy to use device that does not require specialty training.

Connected, Adaptable & Current

Cloud platform will facilitate cross-pollination of data to facilitate the expansion of diagnostic capabilities and enable remote updating.

Robust Population Sensitive Algorithms

RUA Diagnostics is strongly committed to minimizing performance biases across different populations by carefully considering demographic variables at every step of the product development cycle.

© 2024 by RUA Diagnostics.

bottom of page